Organization
Jiangsu ProteLight Pharmaceutical & Biotechnology
1 clinical trial
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients With Mild Infections of Diabetic Foot UlcersStatus: Not yet recruiting, Estimated PCD: 2024-12-30